Background and Aim: The extrastriate cortex is a visual processing structure beyond the striate cortex. This region contains cells that differ in selectivity for different features of stimuli such as color, motion and stereopsis. We studied stereopsis and color vision in patients with right extrastriate cerebral lesions. Methods: Patients with right extrastriate cerebral lesions determined by MRI were recruited among consecutive inpatients. Patients with cognitive impairment (Mini Mental Status Examination score <24) were excluded. An ophthalmologist performed cortical visual testing: visual acuity, stereopsis, color vision and strabismus within 1 week after the insult. Results: Cortical visual testing was performed in 12 patients. Among the patients studied, 11 demonstrated abnormalities: reduced stereoacuity (8/12), color vision abnormalities (7/12). Seven patients showed complex cortical visual abnormalities. However, only 2 patients complained of subjective clinical symptoms. The MRI lesions in patients with disturbance of stereopsis were located in the dorsal occipitoparietal area and the ventral occipitotemporal area. Color vision abnormalities corresponded to lesions in the ventral occipitotemporal area. Conclusions: Patients with lesions in the right extrastriate cortex tend to have disturbance of stereopsis and color vision abnormalities, even in the absence of visual complaints.

Keywords:
Stereopsis, Color vision, Extrastriate cortex
1.
Goodwin J: Disorders of higher cortical visual function. Curr Neurol Neurosci Rep 2002;2:418–422.
2.
Poggio GF, Poggio T: The analysis of stereopsis. Annu Rev Neurosci 1984;7:379–412.
3.
Pratt-Johnson JA: Central disruption of fusional amplitude. Br J Ophthalmol 1973;57:347–353.
4.
Celesia GG, Brigell MG: Cortical blindness and visual processing. Eletroencephalogr Clin Neurophysiol 1999;S49:133–141.
5.
van Noorden GK, Campos EC: Binocular Vision and Ocular Motility, ed 6. St Louis, Mosby, 2002, pp 482–483.
6.
Takayama Y, Sugishita M: Astereopsis induced by repetitive magnetic stimulation of occipital cortex. J Neurol 1994;241:522–525.
7.
Miller WM, Mittenberg W, Carey VM, McMorrow MA, Kushner TE, Weinstein JM: Astereopsis caused by traumatic brain injury. Arch Clin Neuropsychol 1999;14:537–543.
8.
Zeki S, Bartels A: The clinical and functional measurement of cortical (in)activity in the visual brain, with special reference to the two subdivisions (V4 and V4 alpha) of the human colour centre. Philos Trans R Soc Lond B Biol Sci 1999;354:1372–1382.
9.
Chan D, Crutch SJ, Warrington EK: A disorder of colour perception associated with abnormal colour after-images: a defect of the primary visual cortex. J Neurol Neurosurg Psychiatry 2001;71:515–517.
10.
Forte JD, Blessing EM, Buzas P, Martin PR: Contribution of chromatic aberrations to color signals in the primate visual system. J Vis 2006;6:97–105.
11.
Heywood CA, Kentridge RW: Achromatopsia, color vision, and cortex. Neurol Clin 2003;21:483–500.
12.
Garnham L, Sloper JJ: Effect of age on adult stereoacuity as measured by differenct types of stereotest. Br J Ophthalmol 2006;90:91–95.
13.
Horton JC, Hoyt WF: The representation of the visual field in human striate cortex: A revision of the classic Holmes map. Arch Ophthalmol 1991;109:816–824.
14.
Short RA, Graff-Radford NR: Localization of hemiachromatopsia. Neurocase 2001;7:331–337.
15.
Fortin A, Ptito A, Faubert J, et al: Cortical areas mediating stereopsis in the human brain: a PET study. Neuroreport 2002;13:895–898.
16.
Khetpal V, Donahue SP: Cortical visual impairment: etiology, associated findings, and prognosis in a tertiary care setting. J AAPOS 2007;11:235–239.
© 2008 S. Karger AG, Basel
2008
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.